We will create report for your home, including rent value, sales history, homes sold near you, market conditions along
with other related data publicly available that will allow you to gain further insight on the value of your home.
Not exact matches
These risks and uncertainties include, among
others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and
other patent litigation,
related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers;
data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree
with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company
with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as
other factors, which include, without limitation: the uncertain timing of, and risks
relating to, the executive search process; risks
related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of
data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties
related to regulatory application, review and approval processes and Alder's compliance
with applicable legal and regulatory requirements; risks and uncertainties
relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of
others; the uncertain timing and level of expenses associated
with Alder's development and commercialization activities; the sufficiency of Alder's capital and
other resources; market competition; changes in economic and business conditions; and
other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed
with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.
On this platform,
data relating to cryptocurrency transactions could be coupled
with other data (such as IP addresses) associated
with particular blockchain addresses and sold as a single item.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, operating in a highly competitive industry; changes in the retail landscape or the loss of key retail customers; the Company's ability to maintain, extend and expand its reputation and brand image; the impacts of the Company's international operations; the Company's ability to leverage its brand value; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share, or add products; an impairment of the carrying value of goodwill or
other indefinite - lived intangible assets; volatility in commodity, energy and
other input costs; changes in the Company's management team or
other key personnel; the Company's ability to realize the anticipated benefits from its cost savings initiatives; changes in relationships
with significant customers and suppliers; the execution of the Company's international expansion strategy; tax law changes or interpretations; legal claims or
other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the United States and in various
other nations in which we operate; the volatility of capital markets; increased pension, labor and people -
related expenses; volatility in the market value of all or a portion of the derivatives we use; exchange rate fluctuations; risks associated
with information technology and systems, including service interruptions, misappropriation of
data or breaches of security; the Company's ability to protect intellectual property rights; impacts of natural events in the locations in which we or the Company's customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's ownership structure; the impact of future sales of its common stock in the public markets; the Company's ability to continue to pay a regular dividend; changes in laws and regulations; restatements of the Company's consolidated financial statements; and
other factors.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its products from
other brands; the consolidation of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key product categories, increase its market share or add products; an impairment of the carrying value of goodwill or
other indefinite - lived intangible assets; volatility in commodity, energy and
other input costs; changes in the Company's management team or
other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships
with significant customers and suppliers; execution of the Company's international expansion strategy; changes in laws and regulations; legal claims or
other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; failure to successfully integrate the business and operations of the Company in the expected time frame; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility of capital markets; increased pension, labor and people -
related expenses; volatility in the market value of all or a portion of the derivatives that the Company uses; exchange rate fluctuations; risks associated
with information technology and systems, including service interruptions, misappropriation of
data or breaches of security; the Company's inability to protect intellectual property rights; impacts of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; tax law changes or interpretations; and
other factors.
Neither MSCI nor any
other third party involved in or
related to compiling, computing or creating the MSCI
data (the «MSCI Parties») makes any express or implied warranties or representations
with respect to such
data (or the results to be obtained by the use thereof), and the MSCI Parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose
with respect to such
data.
Examples of these risks, uncertainties and
other factors include, but are not limited to the impact of: adverse general economic and
related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and
other international events; the risks and increased costs associated
with operating internationally; our expansion into and investments in new markets; breaches in
data security or
other disturbances to our information technology and
other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or
other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes
relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain
other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace
with developments in technology; amendments to our collective bargaining agreements for crew members and
other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and
other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company
with the Securities and Exchange Commission.
Estimates are based on the analysis of various elements
related to the ad spending market, including macro-level economic conditions; historical trends of the advertising market; historical trends of each medium in relation to
other media; reported revenues from major ad publishers; estimates from
other research firms;
data from benchmark sources; consumer media consumption trends; consumer device usage trends; and eMarketer interviews
with executives at ad agencies, brands, media publishers and
other industry leaders.
We along
with third - party vendors, such as Google use first - party cookies (such as the Google Analytics cookies) and third - party cookies (such as the DoubleClick cookie) or
other third - party identifiers together to compile
data regarding user interactions
with ad impressions, and
other ad service functions as they
relate to our website.
For the purposes of this economic evaluation, the forms were initially used in a
related study funded by the National Institute of Health Research (NIHR) research for patient benefit programme «assessing the impact of a new birth centre on choice and outcome of maternity care in an inner city area,» which will be reported in full elsewhere, comparing the costs of care in a free standing midwifery unit
with care in an obstetric unit in the same trust.16 The
data collected included details of staffing levels, treatments, surgeries, diagnostic imaging tests, scans, drugs, and
other resource inputs associated
with each stage of the pathway through intrapartum and after birth care.
As the
data indicate, participants seemed concerned
with the issue of infant feeding, even when they had not considered
other important issues
relating to pregnancy, childbirth and motherhood.
Opening those massive stores of statistical
data to researchers, watchdogs and that crazy guy who's coding in his basement all night could have serious positive effects, not the least in bringing in a lot more number - crunchers to help
with analysis and also
with relating that
data to
other non-governmental sources.
This images gives a look at how closely
related complex diseases are
with each
other, based on co-morbidity
data.
They then genotyped each sample to determine how the strains were
related, and used previous datasets to compare this
data and integrate the results in a new phylogenetic tree
with other M. bovis found throughout Africa.
In addition, third - party advertising agencies that we work
with may also collect certain information through the use of banner ads and
other forms of advertising and advertising -
related data collection.
Using the same techniques, we produced transcriptome - to - genome alignments beyond those generated
with the de novo transcriptome using existing EST and transcriptome
data for loblolly pine and
other closely
related species (Table 1).
Since the advent of PSA screening, the incidence of patients presenting
with advanced prostate cancer has declined remarkably and death rates from prostate cancer as reported in the National Cancer Database have declined at the rate of 1 % per year since 1990.56
Other data indicate similar declines in prostate cancer
related mortality in the US.
Successful applicants will be granted membership in the MJFF LRRK2 Consortium, where they can share information,
data and resources
with other awardees of this and
other MJFF LRRK2 -
related efforts.
The technician will be provided
with a variety of procedures and techniques previously outlined by established protocols and
other scientific
data related to the production of tissue engineered constructs.
A highly collaborative study led by Professor Thomas Helleday (Karolinska Institutet / SciLifeLab) has now generated comprehensive
data on the individual structural, biochemical and biological properties of 18 human NUDIX proteins, as well as how they
relate to and interact
with each
other.
This is in accordance
with previous reports that decitabine and 5 - azacytidine produce a marked synergistic effect in combination
with suberoylanilide hydroxamic acid and romidepsin in T - lymphoma cell lines by modulating cell cycle arrest and apoptosis.26, 27 As a mechanism of action, KMT2D mutations of B - lymphoma cells promote malignant outgrowth by perturbing methylation of H3K4 that affect the JAK - STAT, Toll - like receptor, or B - cell receptor pathway.28, 29 Here our study indicated that dual treatment
with chidamide and decitabine enhanced the interaction of KMT2D
with the transcription factor PU.1, thereby inactivating the H3K4me - associated signaling pathway MAPK, which is constitutively activated in T - cell lymphoma.13, 30,31 The transcription factor PU.1 is involved in the development of all hematopoietic lineages32 and regulates lymphoid cell growth and transformation.33 Aberrant PU.1 expression promotes acute myeloid leukemia and is
related to the pathogenesis of multiple myeloma via the MAPK pathway.34, 35 On the
other hand, PU.1 is also shown to interact
with chromatin remodeler and DNA methyltransferease to control hematopoiesis and suppress leukemia.36 Our
data thus suggested that the combined action of chidamide and decitabine may interfere
with the differentiation and / or viability of PTCL - NOS through a PU.1 - dependent gene expression program.
Recently, our team released an annotated genome assembly of C. krusei via NCBI Genbank, and we are currently working
with the CDC to assemble genomes and predict genes for C. auris isolates from the
other major clades and
other closely
related species; we plan to share these
data in the coming weeks.
Characteristics and nutritional intake of those who died of an inflammation -
related disease were compared
with characteristics of those who died of
other causes and
with those still alive at 13 - y follow - up by using the Wilcoxon's test for continuous
data and chi - square test for categorical
data (or Fisher's test for frequencies ≤ 5).
Accordingly, Mama Natural assumes no liability for or
relating to the delay, failure, interruption, or corruption of any
data or
other information transmitted in connection
with use of the Mama Natural Site.
But now the body, which launched at the end of 2013, is looking to those that are closely involved
with the dating sector «through the supply of technical, financial, advice,
data -
related and
other services and goods.»
We begin
with an oft - cited
data point: after controlling for differences in education, experience, race, gender, marital status, and
other earnings -
related characteristics, public school teachers receive considerably lower total annual salaries than private workers.
SETDA profiled the emerging work of inBloom in our May 2013 report, Transforming
Data to Information, along with over a dozen other interoperability and data standards efforts related to meeting the information needs of K - 12 educators, school leaders and policymakers who — while awash in data — too often still lack the ability to easily -LSB-
Data to Information, along
with over a dozen
other interoperability and
data standards efforts related to meeting the information needs of K - 12 educators, school leaders and policymakers who — while awash in data — too often still lack the ability to easily -LSB-
data standards efforts
related to meeting the information needs of K - 12 educators, school leaders and policymakers who — while awash in
data — too often still lack the ability to easily -LSB-
data — too often still lack the ability to easily -LSB-...]
Local educators, in partnership
with other stakeholders, can then use an ongoing
data based decision - making model utilizing secondary transition
data related to graduation (Indicator 1), dropout (Indicator 2), transition compliance of the IEP (Indicator 13), and post-school outcomes (Indicator 14) to improve in - school transition programs for youth
with disabilities.
In successful schools, which typically operate as strong professional learning communities, teachers systematically study student assessment
data,
relate the
data to their instruction, and work
with others to refine their teaching practices (Fullan, 2000).
The Special Education Teacher will be responsible for the successful completion of the following tasks: + Manage and provide instructional guidance, virtual teaching and general strategies for a caseload of students; + Develop, write and help implement IEPs; + Evaluate tests and assessments, complete report cards and conduct parent conferences; + Communicate regularly
with parents / learning coaches of students
with special needs to insure that their IEP goals are being met, and that their needs are addressed in a timely and appropriate fashion; + Consult
with teachers and coordinate the implementation of specially designed instruction as defined in the IEP regarding students
with specific needs and potential learning issues; + Provide direct services to students including services delivered through web - conferencing software, as needed; + Schedule, organize and conduct IEP
related meetings in a virtual environment, as needed; + Participate in the school's Student Support Team; help teachers and learning coaches develop and implement program modifications and strategies for all students; + Assist, as needed,
with the organization and proper implementation of all paperwork, documentation and procedures for the IEP process; + Assist
with locating service providers for students needing
related services as mandated by their IEPs; + Assist
with negotiating and executing contracts
with service providers for students requiring such services; + Maintain accurate and up - to - date
data in the school's Learning Management System and special education software; + Assist
with administering state testing and coordinate the special adaptations that are required based on the IEP; and +
Other duties as assigned.
In particular, Meredith Honig and Nitya Venkateswaran argue that school practitioners work
with data and evidence within a context in which
other related actors, especially at the central offices of school systems, are also interacting and interpreting the same
data as part of their job responsibilities.
@Nick I certainly do not agree
with the point that there is not enough
data M / C manufacturers have at their disposal
related to MTBF of their engines and
other parts.
On December 1st, Michael Morisy, co-founder of MuckRock, a website that helps people file FOIA requests
with the government, asked the FBI for any manuals, documents or
other written material it might have
related to the FBI's use of
data gathered by Carrier IQ.
There are lots of really smart people and groups working on standards and practices
related to how someone «asserts» their online identity and their connections
with others — and how web services should respect how individuals utilize such personal
data.
And in a few weeks, the researchers will reveal more interesting
data from their survey participants — about «reading habits and their interactions
with their libraries
related to e-books and
other digital content!»
In a
related bombshell, Facebook announced it was dropping Experian and TransUnion as
data partners, along
with seven
other data brokers including Acxiom and Cisco, as part of its effort to improve customer
data privacy.
By selecting the appropriate hypertext link, you may access the Official Statements (or Preliminary Official Statements) of the Maine Educational Loan Authority (MELA) or the Finance Authority of Maine (FAME) into which MELA was merged in October 2015 (collectively referred to herein as «Official Statements»)
with respect to certain series of their outstanding Student Loan Revenue Bonds, and certain
other documents,
data and reports pertaining to their supplemental education loan programs, financial information, portfolio information or information
relating to their Student Loan Revenue Bonds.
This information, combined
with health -
related data from
other areas of the company's operations, is used not only to help breeders improve their practices, but also to help Hunte identify potential issues in breeding lines.
VetLIVE.com, LLC assumes no liability for or
relating to the delay, failure, interruption, or corruption of any
data or
other information transmitted in connection
with the use of VetLIVE.com Site.
We along
with third - party vendors, such as Google use first - party cookies (such as the Google Analytics cookies) and third - party cookies (such as the DoubleClick cookie) or
other third - party identifiers together to compile
data regarding user interactions
with ad impressions and
other ad service functions as they
relate to our website.
By creating an Account, You agree that You do not own the Account, any user names created on the Account, any Content stored or associated
with an Account (such as digital and / or virtual assets, achievements, virtual currency, and
other Downloadable Content), or
related data associated
with the Account.
3.8 Research
data related to publications must be available for discussion
with other researchers.
The process takes precisely measured point
data and then averages it in some fashion
with other data from farther away, coming up
with effectively imaginary values (estimates) for grid cells that are only vaguely
related to the original, precise
data.
«Permitted Use»: (1) Installing, operating, maintaining, removing, replacing and collecting
data from meteorological towers, stations and anemometers, conducting avian, archeological and biological assessments, environmental assessments, soil and preconstruction analysis, and
other studies and evaluations deemed necessary by Grantee for purposes of evaluating the Wind Resources of the Premises, exercising the rights granted to Grantee hereunder, and developing the Wind Energy Project; (2) Constructing, installing, operating, accessing, maintaining and removing (including, when necessary, replacing)(a) WTGs on WTG Pads on the Premises for the conversion of Wind Resources to electricity, and including replacing WTGs for purposes of repowering for conversion of Wind Resources to electricity on WTG Pads located on the Premises and / or in connection or conjunction
with other real property on which the Wind Energy Project is located; and (b) all
related Improvements (i) necessary or convenient to Grantee in conjunction
with WTGs for the Wind Energy Project (ii) for the use by Grantee in collecting, transmitting or otherwise making electricity from the WTGs on the Wind Energy Project marketable and available for sale; or (iii) for the use by Grantee for access to and from the Improvements or a public right of way to the WTGs for the Wind Energy Project (in each case, whether or not such WTGs are on the Premises), or (3) uses otherwise permitted herein.
In the results section both
data records are thus shown
with respect to their «native» climatology, mainly in order to more directly
relate the ERA - Interim soil moisture
with other ERA - Interim variables.
In most cases, these range from about 2 to 4.5 C per doubled CO2 within the context of our current climate —
with a most likely value between 2 and 3 C. On the
other hand, chapter 9 describes attempts ranging far back into paleoclimatology to
relate forcings to temperature change, sometimes directly (
with all the attendant uncertainties), and more often by adjusting model parameters to determine the climate sensitivity ranges that allow the models to best simulate
data from the past — e.g., the Last Glacial Maximum (LGM).
That IPCC, the organization which
others say in considerable detail is unreliable due to its assessment reports having massive problems
with transparency,
data availability and due diligence and
other such
related problems.
Re the uncertainty issue, I don't recognize this as a «strategy» of mine, nor anyhow that it is mutually exclusive
with other ideas (e.g. your «third way»), nor indeed that I have * any * «strategy»
related to in - domain info in the climate domain (i.e. climate science or climate
data), nor come to that I am combating the «global warming zealotry» using any such strategy or magic formula anyhow.
We analyze the XCP
data under our «Mixing» grant, and
with other data, we will use them to track changes in internal wave energy and
related mixing.